Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevalence of Antiphospholipid Antibodies in Ankylosing Spondylitis
NCT02809300Unknown
- Sponsor
- CHU de Reims
- Start
- Nov 2015
- Primary completion
- Mar 2017
- Countries
- 1
01
Overview
Single-arm trial, sponsored by CHU de Reims. Primary endpoint: Presence or absence of Anti-Phospholipid Antibodies (APLA) at 12 weeks. Status: unknown.
Beyond the preview
Go deeper on NCT02809300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02809300.